TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9368162

Group type: EXPERIMENTAL
Intervention: Diclofenac 0.1% eyedrops
Number of subjects: 281

Group type: COMPARATOR
Intervention: Control regimen (brief course of steroids)
Number of subjects: 281
Study: 1547059

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.036 mg kg‐1
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Neostigmine 0.071 mg kg‐1
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Edrophonium 1.43 mg kg‐1
Number of subjects: 31
Study: 3904908

Group type: EXPERIMENTAL
Intervention: diethylstilboestrol 3 mg/day
Number of subjects: 140

Group type: COMPARATOR
Intervention: estramustine 560 mg/day
Number of subjects: 140
Study: 31779993

Group type: EXPERIMENTAL
Intervention: Cassia alata Linn tea
Number of subjects: 90

Group type: COMPARATOR
Intervention: Warm water
Number of subjects: 90
Study: 29452901

Group type: EXPERIMENTAL
Intervention: Short-course radiotherapy (25 Gy in five fractions)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Commonly used radiotherapy (40 Gy in 15 fractions)
Number of subjects: 0
Study: 27831636

Group type: EXPERIMENTAL
Intervention: Sublingual administration of dust mite drops, once per day, gradually increasing the dose to reach a high maintenance level.
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Sublingual administration of dust mite drops
Number of subjects: 156
Study: 24004349

Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplements (800 IU/day)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 164
Study: 22541754

Group type: COMPARATOR
Intervention: PF-00734200 10 mg single dose
Number of subjects: 16

Group type: COMPARATOR
Intervention: PF-00734200 100 mg single dose
Number of subjects: 16

Group type: COMPARATOR
Intervention: PF-00734200 20 mg once daily for 6 days
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 20565159

Group type: EXPERIMENTAL
Intervention: Culturally specific smoking messages
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard smoking messages
Number of subjects: 243

Group type: COMPARATOR
Intervention: Culturally specific exercise/weight messages
Number of subjects: 243

Group type: COMPARATOR
Intervention: Standard exercise/weight messages
Number of subjects: 243
Study: 18384853

Group type: COMPARATOR
Intervention: Supportive telephone contact by a urology nurse (Control)
Number of subjects: 216

Group type: EXPERIMENTAL
Intervention: Weekly postoperative pelvic floor muscle training (PFMT) (Treatment)
Number of subjects: 216
Study: 15875528

Group type: EXPERIMENTAL
Intervention: Ciclesonide 320 microg once daily
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Ciclesonide 640 microg twice daily
Number of subjects: 164

Group type: COMPARATOR
Intervention: Fluticasone propionate 880 microg twice daily
Number of subjects: 164
Study: 12740791

Group type: EXPERIMENTAL
Intervention: Tacrolimus (FK506)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Cyclosporine (CsA)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control (Healthy Volunteers)
Number of subjects: 32
Study: 10561630

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (6 g loading dose in 100 mL isotonic sodium chloride solution, followed by 2 g/h infusion for 3 hours at 125 mL/h)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sodium chloride solution (100 mL isotonic sodium chloride solution, similar infusion rate)
Number of subjects: 0
Study: 9046544

Group type: EXPERIMENTAL
Intervention: Functional treatment using specially designed compression pads, elevation of the injured foot (24 h), repeated elastic wrapping, early full weight-bearing and proprioceptive range-of-motion training (Group I, n = 46)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional treatment with an elastic bandage, partial weight bearing and crutches until pain subsided (Group II, n = 40)
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Functional treatment (Group I)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional treatment (Group II)
Number of subjects: 86
Study: 1989755

Group type: EXPERIMENTAL
Intervention: Dantrolene sodium (2 mg/kg body weight iv)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Dantrolene sodium
Number of subjects: 52
Study: 6340700

Group type: EXPERIMENTAL
Intervention: carteolol hydrochloride (Endak, Endak mite) for 4 weeks after a 7-day placebo period
Number of subjects: 40

Group type: COMPARATOR
Intervention: pindolol (standard medication)
Number of subjects: 40
Study: 30222818

Group type: EXPERIMENTAL
Intervention: 20-gauge pars plana incision with suture
Number of subjects: 22

Group type: COMPARATOR
Intervention: 3.5-mm corneal incision with suture
Number of subjects: 22
Study: 29441845

Group type: EXPERIMENTAL
Intervention: Ivy leaves cough liquid containing EA 575®
Number of subjects: 181

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 181
Study: 24819911

Group type: COMPARATOR
Intervention: Standard dose escalation scheme of dipyridamole
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: Slow dose escalation scheme of dipyridamole
Number of subjects: 114
Study: 22802432

Group type: EXPERIMENTAL
Intervention: 2009 H1N1 vaccine and seasonal TIV (TIV; split virion)
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: 2009 H1N1 vaccine
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: TIV
Number of subjects: 531
Study: 19864172

Group type: EXPERIMENTAL
Intervention: Group psychotherapy
Number of subjects: 16

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 16
Study: 18540726

Group type: EXPERIMENTAL
Intervention: Decisional Balance Scale administered via computerized and paper versions
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Hierarchical confirmatory factor analysis multi‐trait multi‐method approach (HCFA MTMM)
Number of subjects: 2334

Group type: EXPERIMENTAL
Intervention: Decisional Balance for smoking in adolescence
Number of subjects: 2334
Study: 15785936

Group type: EXPERIMENTAL
Intervention: Ibuprofen co-treatment
Number of subjects: 204

Group type: COMPARATOR
Intervention: No ibuprofen co-treatment (Control)
Number of subjects: 204
Study: 12017805

Group type: EXPERIMENTAL
Intervention: Oral anticoagulants
Number of subjects: 0

Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study: 10426160

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally once a day for 4 days
Number of subjects: 9
Study: 8775645

Group type: EXPERIMENTAL
Intervention: Sodium citrate (0.5 g.kg‐1 body weight)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Placebo (calcium carbonate, 0.5 g.kg‐1 body weight)
Number of subjects: 6
Study: 2207450

Group type: COMPARATOR
Intervention: CSP alone (n = 39)
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: CSP + MTX (n = 37)
Number of subjects: 76
Study: 6105392

Group type: EXPERIMENTAL
Intervention: Prostacyclin (5 ng kg‐1 min‐1) during dialysis
Number of subjects: 0
Study: 31679107

Group type: EXPERIMENTAL
Intervention: Pelvic lymphadenectomy (pLA)
Number of subjects: 0
Study: 31211327

Group type: EXPERIMENTAL
Intervention: Catheter Ablation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Medical Therapy
Number of subjects: 0
Study: 27865057

Group type: EXPERIMENTAL
Intervention: SGA group
Number of subjects: 0

Group type: COMPARATOR
Intervention: AGA group
Number of subjects: 0
Study: 26356419

Group type: EXPERIMENTAL
Intervention: Lisinopril
Number of subjects: 179

Group type: COMPARATOR
Intervention: Atenolol
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Volume control (proxy for ambulatory systolic blood pressure)
Number of subjects: 179

Group type: EXPERIMENTAL
Intervention: Adjustment for inferior vena cava diameter
Number of subjects: 179
Study: 23330835

Group type: EXPERIMENTAL
Intervention: Bitter chocolate
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Orange juice
Number of subjects: 180

Group type: COMPARATOR
Intervention: Control
Number of subjects: 180
Study: 22235525

Group type: EXPERIMENTAL
Intervention: Prototype medication drawer (Drawer 2)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Baseline medication drawer (Drawer 1)
Number of subjects: 26
Study: 19516186

Group type: EXPERIMENTAL
Intervention: Etoricoxib
Number of subjects: 23504

Group type: COMPARATOR
Intervention: Diclofenac
Number of subjects: 23504

Group type: COMPARATOR
Intervention: Calcium Channel Blockers (CCB)
Number of subjects: 23504
Study: 17410045

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2, day 1, every 3 weeks for eight cycles)
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Pemetrexed (500 mg/m2 for cycles 1 and 2) followed by Gemcitabine (1200 mg/m2, days 1 and 8, every 3 weeks for cycles 3 and 4, repeated for a total of eight cycles)
Number of subjects: 87
Study: 15482398

Group type: EXPERIMENTAL
Intervention: Sulphadoxine-pyrimethamine (SP)
Number of subjects: 600

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 600
Study: 11535311

Group type: EXPERIMENTAL
Intervention: Chromatographically purified rabies vaccine (CPRV)
Number of subjects: 680

Group type: COMPARATOR
Intervention: Human diploid cell vaccine (HDCV)
Number of subjects: 680
Study: 10617953

Group type: EXPERIMENTAL
Intervention: Alcohol-reconstituted red wine (ARW)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Dealcoholized red wine (DRW)
Number of subjects: 9
Study: 9179581

Group type: EXPERIMENTAL
Intervention: Condom availability program in high schools
Number of subjects: 9

Group type: COMPARATOR
Intervention: Comparison schools (control group)
Number of subjects: 9
Study: 1412141

Group type: EXPERIMENTAL
Intervention: Mebendazole
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 3931467

Group type: EXPERIMENTAL
Intervention: Glyburide plus insulin
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo plus insulin
Number of subjects: 22
Study: 30834441

Group type: EXPERIMENTAL
Intervention: Coffee consumption (≥4 cups of total coffee/day)
Number of subjects: 22948
Study: 28322669

Group type: EXPERIMENTAL
Intervention: 12-month walking intervention
Number of subjects: 81
Study: 26609786

Group type: EXPERIMENTAL
Intervention: Enoxaparin administered through venous line
Number of subjects: 16

Group type: COMPARATOR
Intervention: Enoxaparin administered through arterial line
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Venous line administration of enoxaparin
Number of subjects: 16
Study: 24921919

Group type: EXPERIMENTAL
Intervention: Neoadjuvant treatment and surgery
Number of subjects: 375

Group type: COMPARATOR
Intervention: Definitive chemoradiotherapy
Number of subjects: 375
Study: 22181014

Group type: EXPERIMENTAL
Intervention: High caseworker support
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: High caseload size
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: High emphasis on employment
Number of subjects: 1098

Group type: EXPERIMENTAL
Intervention: Economic trajectories
Number of subjects: 1098
Study: 19918972

Group type: EXPERIMENTAL
Intervention: Acetaminophen (4-g bolus dose)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 17852632

Group type: EXPERIMENTAL
Intervention: Step-down regimen (5.0 mg/kg per day starting dose and decreasing regimen)
Number of subjects: 61

Group type: COMPARATOR
Intervention: Standard regimen (2.5 mg/kg per day starting dose and increasing regimen)
Number of subjects: 61
Study: 16159831

Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control (saline)
Number of subjects: 75
Study: 12121425

Group type: EXPERIMENTAL
Intervention: Prone back extension exercise no. 5 (raising trunk, legs, and arms)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Prone back extension exercises (other than exercise no. 5)
Number of subjects: 20
Study: 10633202

Group type: EXPERIMENTAL
Intervention: Weekly ferrous sulfate (60 mg elemental iron)
Number of subjects: 193

Group type: COMPARATOR
Intervention: Daily ferrous sulfate (60 mg elemental iron)
Number of subjects: 193
Study: 7759724

Group type: EXPERIMENTAL
Intervention: Bioabsorbable hemostatic puncture closure device
Number of subjects: 435

Group type: COMPARATOR
Intervention: Manual pressure control
Number of subjects: 435
Study: 2275646

Group type: EXPERIMENTAL
Intervention: Reverberant room with T = 0.54 s
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Reverberant room with T = 1.55 s
Number of subjects: 3

Group type: COMPARATOR
Intervention: Sound suite (quiet)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Noise condition
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Interaction of noise and room reverberation
Number of subjects: 3
Study: 30476654

Group type: EXPERIMENTAL
Intervention: Colistin/rifampicin combination therapy
Number of subjects: 9

Group type: COMPARATOR
Intervention: Colistin monotherapy
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Colistin/rifampicin combination therapy with 'partial synergy'
Number of subjects: 9

Group type: COMPARATOR
Intervention: Colistin/rifampicin combination therapy with 'indifferent' results
Number of subjects: 9
Study: 28412111

Group type: EXPERIMENTAL
Intervention: Apneic oxygen insufflation (AOI) at 3 L/min for 30 minutes during one-lung ventilation (OLV)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Non-AOI (control group)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Apneic oxygen insufflation (AOI)
Number of subjects: 90
Study: 25520389

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 6390

Group type: EXPERIMENTAL
Intervention: Aspirin and/or NSAIDs
Number of subjects: 6390

Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 6390
Study: 23840145

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy (antox version 1.2-based)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Antioxidant therapy
Number of subjects: 7
Study: 22929851

Group type: EXPERIMENTAL
Intervention: Septal quilting
Number of subjects: 85

Group type: COMPARATOR
Intervention: BIPP packing
Number of subjects: 85
Study: 20025374

Group type: EXPERIMENTAL
Intervention: Brief motivational interventions (BMI)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Alcohol expectancy challenge (AEC)
Number of subjects: 335
Study: 17055622

Group type: EXPERIMENTAL
Intervention: Reformulated oral cholera vaccine
Number of subjects: 144

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study: 15326073

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg/d
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control
Number of subjects: 70
Study: 11883335

Group type: EXPERIMENTAL
Intervention: Biopsy urease test
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: IgG ELISA
Number of subjects: 156
Study: 9449446

Group type: EXPERIMENTAL
Intervention: Covering colostomy (n = 19)
Number of subjects: 38

Group type: COMPARATOR
Intervention: No covering colostomy (n = 19)
Number of subjects: 38
Study: 7677828

Group type: EXPERIMENTAL
Intervention: Active allergen avoidance treatment (n = 17)
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo (n = 18)
Number of subjects: 35
Study: 2904753

Group type: EXPERIMENTAL
Intervention: Doxazosin (2 to 8 mg)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Atenolol (100 mg)
Number of subjects: 40
Study: 30918221

Group type: COMPARATOR
Intervention: Serum TG level <100 mg/dL
Number of subjects: 652

Group type: EXPERIMENTAL
Intervention: Serum TG level ≥100 mg/dL
Number of subjects: 652
Study: 27778264

Group type: EXPERIMENTAL
Intervention: Conventional treatment plus Chinese herbal medicines (CHMs) for benefiting qi and activating blood circulation
Number of subjects: 702

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 702
Study: 26219416

Group type: EXPERIMENTAL
Intervention: Morning meal (0800 hours)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Evening meal (2000 hours)
Number of subjects: 20
Study: 23288773

Group type: EXPERIMENTAL
Intervention: Cross-eccentric exercise (CEE) 3 times per week
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Cross-eccentric exercise (CEE) 5 times per week
Number of subjects: 42

Group type: COMPARATOR
Intervention: Control group (no CEE)
Number of subjects: 42
Study: 22126827

Group type: EXPERIMENTAL
Intervention: CVD risk message
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: Planning tool
Number of subjects: 781

Group type: EXPERIMENTAL
Intervention: CVD risk message plus planning
Number of subjects: 781

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 781
Study: 18434639

Group type: EXPERIMENTAL
Intervention: 2.5 g/day mycophenolate mofetil (MMF) plus 20 mg/day prednisone
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo plus 20 mg/day prednisone
Number of subjects: 80
Study: 17057572

Group type: EXPERIMENTAL
Intervention: Laparoscopic cholecystectomy (group L)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Mini-laparotomy cholecystectomy (group M)
Number of subjects: 88
Study: 13677549

Group type: EXPERIMENTAL
Intervention: Ortho Tri-Cyclen LO (norgestimate 180/215/250 microg/EE 25 microg)
Number of subjects: 864

Group type: COMPARATOR
Intervention: Loestrin Fe 1/20 (norethindrone acetate 1 mg/EE 20 microg)
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Ortho Tri-Cyclen LO
Number of subjects: 864

Group type: COMPARATOR
Intervention: Loestrin Fe 1/20
Number of subjects: 864

Group type: EXPERIMENTAL
Intervention: Ortho Tri-Cyclen to Ortho Tri-Cyclen LO switchovers
Number of subjects: 864
Study: 10766680

Group type: EXPERIMENTAL
Intervention: Invasive management strategy
Number of subjects: 413
Study: 8874906

Group type: EXPERIMENTAL
Intervention: Oral clonidine (5 micrograms . kg‐1) administered 1.5 hr before surgery, and at 12 hr and 24 hr after initial dose
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Oral clonidine
Number of subjects: 39

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39
Study: 1411952

Group type: EXPERIMENTAL
Intervention: 24-hour treatment (cefoxitin or cefotetan)
Number of subjects: 515

Group type: COMPARATOR
Intervention: 5-day treatment
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: 24-hour treatment (cefoxitin or cefotetan) in high-risk group (colon wounds)
Number of subjects: 515

Group type: COMPARATOR
Intervention: 5-day treatment in high-risk group (colon wounds)
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: 24-hour treatment (cefoxitin or cefotetan) in high-risk group (ATI > 25)
Number of subjects: 515

Group type: COMPARATOR
Intervention: 5-day treatment in high-risk group (ATI > 25)
Number of subjects: 515
Study: 2932705

Group type: EXPERIMENTAL
Intervention: Diazepam 5 mg (group B)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: Diazepam 10 mg (group C)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Placebo (group A)
Number of subjects: 81

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 81
Study: 28906317

Group type: EXPERIMENTAL
Intervention: PEG3350 with electrolytes (PEG3350 + E)
Number of subjects: 97

Group type: COMPARATOR
Intervention: PEG4000 without electrolytes (PEG4000)
Number of subjects: 97
Study: 28716141

Group type: EXPERIMENTAL
Intervention: Multicomponent activation therapy for people with MCI or mild to moderate dementia and a brief telephone intervention for informal caregivers.
Number of subjects: 346

Group type: COMPARATOR
Intervention: Care as usual (waitlist control group).
Number of subjects: 346

Group type: EXPERIMENTAL
Intervention: Multicomponent activation therapy and caregiver counselling.
Number of subjects: 346
Study: 26329163

Group type: EXPERIMENTAL
Intervention: Incredible Years Parents and Babies Program
Number of subjects: 128

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 128
Study: 23945510

Group type: EXPERIMENTAL
Intervention: Intranasal dexmedetomidine 1 μg/kg
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Intravenous dexmedetomidine 1 μg/kg
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.9% saline (Control)
Number of subjects: 60
Study: 22042184

Group type: EXPERIMENTAL
Intervention: Horse riding simulator (RS)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional physical therapy (CT)
Number of subjects: 40
Study: 18427233

Group type: EXPERIMENTAL
Intervention: Isometric contraction of the masseter muscles
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Baseline measurements
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Simulated job interview (inducing cardiovascular responses)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (pain-free individuals)
Number of subjects: 0
Study: 16950290

Group type: EXPERIMENTAL
Intervention: Venom Immunotherapy (VIT)
Number of subjects: 193

Group type: COMPARATOR
Intervention: EpiPen
Number of subjects: 193
Study: 15367074

Group type: EXPERIMENTAL
Intervention: Telephone counseling (up to 5 sessions)
Number of subjects: 3522

Group type: COMPARATOR
Intervention: Self-help booklets only
Number of subjects: 3522
Study: 11305625

Group type: EXPERIMENTAL
Intervention: Estimated food diary record (ED) method
Number of subjects: 72

Group type: COMPARATOR
Intervention: Weighed intake record method (WI)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Doubly labelled water (DLW) method
Number of subjects: 72
Study: 9048792

Group type: COMPARATOR
Intervention: Epinephrine (1 mg intravenously)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Vasopressin (40 U intravenously)
Number of subjects: 40
Study: 8328080

Group type: EXPERIMENTAL
Intervention: Budesonide (800 micrograms twice daily)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Beclomethasone dipropionate (750 micrograms twice daily)
Number of subjects: 40
Study: 3551508

Group type: EXPERIMENTAL
Intervention: Antacid treatment (10 ml of an antacid suspension, buffering capacity 85 mmol/10 ml, administered 1 and 3 hours after each meal and at bedtime)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cimetidine (400 mg b.i.d.)
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Antacid treatment
Number of subjects: 67

Group type: COMPARATOR
Intervention: Cimetidine treatment
Number of subjects: 67
Study: 29337126

Group type: EXPERIMENTAL
Intervention: Rigid Plate Fixation (RPF)
Number of subjects: 236

Group type: COMPARATOR
Intervention: Wire Cerclage (WC)
Number of subjects: 236
Study: 27178435

Group type: EXPERIMENTAL
Intervention: Bitopertin 3 mg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bitopertin 10 mg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bitopertin 30 mg
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Bitopertin 60 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: RG7118 15 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: RG7118 30 mg
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 24768084

Group type: EXPERIMENTAL
Intervention: Masai Barefoot Technology shoes
Number of subjects: 17

Group type: COMPARATOR
Intervention: Control shoes
Number of subjects: 17